INTRODUCTION.
“Genomic regions” is the topic of this blog post. Although anyone can get a DNA company, such as Ancestry, Familytree & 23&Me to give you “chromosomal paints”; the next steps to reading the nucleic “eighty-seven (87) & mitochondria one (1) reading regions” needs to be addressed.
I am going present genomic group #G (shown ABOVE) which is chromosome #21, chromosome #22, and chromosomes #Y (shown BELOW).
Microsoft WORD has a “read-aloud” function. If you “copy & paste” the traits of genomic Group #G into a Microsoft WORD document; and press the “read-aloud” button you get a lesson. This lesson is reading-aloud of the Gateway chromosomes (free at Wikipedia); but now you just listen. Listening to the “read-aloud” over and over, allows you to learn the “nucleic eighty-seven (87) & mitochondria one (1) reading regions”.
Region Y1p1 Traits.
Short stature homeo-box, X-linked. SHOX
Short stature. SHOXY
Leri-Weill dyschondrosteosis. LWD
Langer mesomelic dysplasia. LMD
Interleukin-3 receptor, Y-chromosomal. IL3RA
Sex-determining region Y (testis determining). SRY
Region Y1q1 Traits.
Gonadal dysgenesis, XY type. GDMN
Protocadherin 11, Y-linked. PCDH11Y
Male infertility due to spermatogenic failure. SPGFY2
Growth control, Y-chromosome influenced. GCY
Chromodomain proteins. CDY1
Retinitis pigmentosa, Y-linked. RPY
Region 21p1 Traits.
Coxsackie and adenovirus receptor. CXADR
Myeloproliferative syndrome, transient. MST
Amyloidsis, cerebroarterial, Dutch-type. CAA
Leukemia, transient, of Down syndrome. TAM
Alzheimer disease, APP-related. AD1
Enterokinase deficiency. PRSS7
Schizophrenia, chronic. SCZD
Multiple carboxylase deficiency. HLCS
Usher syndrome, autosomal recessive. USH1
T-cell lymphoma invasion and metastasis. TIAM1
Amytrophic lateral sclerosis. ALS1
Mycobacterial infection, atypical. IMD27A
Oligomycin sensitivity. OSCP
Down syndrome (critical region). DCR
Jervell and Lange-Nielsen syndrome. JLNS1
Autoimmune polyglandular disease, type 1. APS1
REGION 21q1 TRAITS.
Long QT syndrome. LQT1
Bethlem myopathy. BTHLM1A
Down syndrome cell adhesion molecule. DSCAM
Epilepsy, progressive myoclonic. EPM1
Homocystinuria. CBS
Holoprosencephaly, alobar. HPE1
Cataract, congenital, autosomal dominant. CATC1
Knobloch syndrome. KNO1
Deafness, autosomal recessive. DFNB98
Hemolytic anemia. GPI
Myxovirus (influenza) resistance. MX1
Breast cancer. TTF1
Leukemia, acute myeloid. AML
Platelet disorder, with myeloid malignancy. FPDMM
Region 22p1 Traits.
Cat eye syndrome. CES
DiGeorge syndrome. DGS2
Thrombophilia. THPH10
Velocardiofacial syndrome. VCFS
Rhabdoid predisposition syndrome, familial. RTPS1
Schindler disease. NAGA
Schizophrenia susceptibility locus. SCZD15
Kanzaki disease. NAGA
Bernard-Soulier syndrome, type B. BSS
NAGA deficiency, mild. NAGA
Giant platelet disorder, isolated. GP1BB
Epilepsy, partial. FFEVF1
Hyperprolinemia. HRPRO1
Glutathioninuria. GSSD
Cataract, cerulean, type 2. CTRCT3
Opitz G syndrome, type II. GBBB
Leukemia, chronic myeloid. CML
Ubiquitin fusion degradation. UFD1L
Ewing sarcoma. ES
Transcobalamin deficiency. TCN2D
Neuroepithelioma. PNE
Heme oxygenase deficiency. HMOX1D
Li-Fraumeni syndrome. LFS
Leukemia inhibitory factor. LIF
Fechtner syndrome. FTNS
Sorsby fundus dystrophy. SFD
REGION 22q1 TRAITS.
Amyotrophic lateral sclerosis. ALS1
Neurofibromatosis, type 2. NF2
Pulmonary alveolar proteinosis. SMDP4
Meningioma, NF2-related, sporadic. NF2
Meningioma, SID-related. MN1
Schwannoma, sporadic. SWN1
Dermatofibrosarcoma protuberans. DFSP
Neurolemmomatosis. NF1
Giant-cell fibroblastoma. DFSP
Malignant mesothelioma, sporadic. MESOM
Spinocerebellar ataxia. SCA10
Deafness, autosomal dominant. DFNA17
Waardenburg-Shah syndrome. WS2E
Colorectal cancer. CRC
Yemenite deaf-blind hypopigmentation syndrome. SOX10
Cardioencephalomyopathy, fatal infantile. MC4DN2
Debrisoquine sensitivity. CYP2D6
Adenylosuccinase deficiency. ADSLD
Polycystic kidney disease. PKD
Autism, succinylpurinemic. ADSLD
Leukodystrophy, metachromatic. MLD
Glucose/Galactose malabsorption. GGM
Myoneurogastrointestinal encephalopathy. MTDPS1
Benzodiazepine receptor, peripheral type. BZRP
Leukoencephalopathy. MLC1
Methemoglobinemia, types I and II. CYB5R3
